These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14954119)

  • 21. Inhibitory activity of 8-beta-carbobenzyloxyaminomethyl-1,6-dimethyl-10-alpha-ergoline towards stimulant effects by 5-hydroxytryptamine and amphetamine on liver fluke, Fasciola hepatica, in vitro.
    Beretta C; Locatelli A
    J Pharm Pharmacol; 1968 Oct; 20(10):744-8. PubMed ID: 4386741
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterisation of a novel panel of polymorphic microsatellite loci for the liver fluke, Fasciola hepatica, using a next generation sequencing approach.
    Cwiklinski K; Allen K; LaCourse J; Williams DJ; Paterson S; Hodgkinson JE
    Infect Genet Evol; 2015 Jun; 32():298-304. PubMed ID: 25796359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the effective dose of an experimental intramuscular formulation against immature and adult Fasciola hepatica in sheep.
    Ibarra-Velarde F; Vera-Montenegro Y; Flores-Ramos M; Cantó-Alarcon GJ; Hernández-Campos A; Alcala-Canto Y; Castillo R
    Vet Parasitol; 2018 Aug; 260():38-44. PubMed ID: 30197011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hexachloroethane-bentonite suspension for controlling the common liver fluke, Fasciola hepatica, in cattle in the Gulf coast region of Texas.
    OLSEN OW
    Am J Vet Res; 1947 Oct; 8(29):353-66. PubMed ID: 20268037
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of a multiplex quantitative PCR assay for detection and quantification of DNA from Fasciola hepatica and the intermediate snail host, Austropeplea tomentosa, in water samples.
    Rathinasamy V; Hosking C; Tran L; Kelley J; Williamson G; Swan J; Elliott T; Rawlin G; Beddoe T; Spithill TW
    Vet Parasitol; 2018 Aug; 259():17-24. PubMed ID: 30056979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a cysteine protease inhibitor on Fasciola hepatica (liver fluke) fecundity, egg viability, parasite burden, and size in experimentally infected sheep.
    Alcala-Canto Y; Ibarra-Velarde F; Sumano-Lopez H; Gracia-Mora J; Alberti-Navarro A
    Parasitol Res; 2007 Feb; 100(3):461-5. PubMed ID: 17024356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Praziquantel is mostly ineffective: treatment of fasciola hepatica infection (large liver fluke)].
    Schubert S; Phetsouvanh R
    Z Arztl Fortbild (Jena); 1990; 84(14):705-7. PubMed ID: 2264356
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of treatment of cattle for liver fluke at housing: influence of differences in flukicidal activity against juvenile Fasciola hepatica.
    Forbes AB; Reddick D; Stear MJ
    Vet Rec; 2015 Mar; 176(13):333. PubMed ID: 25549916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine cyclic 3',5'-monophosphate in the liver fluke, Fasciola hepatica. I. Activation of adenylate cyclase by 5-hydroxytryptamine.
    Abrahams SL; Northup JK; Mansour TE
    Mol Pharmacol; 1976 Jan; 12(1):49-58. PubMed ID: 176567
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in rabbit liver sterol patterns after administration of carbon tetrachloride in doses effective against Fasciola hepatica, the liver fluke.
    Posthuma D; Vaatstra WJ
    Biochem Pharmacol; 1971 Jun; 20(6):1133-8. PubMed ID: 5118112
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the action of some enzymes on the cyst wall of isolated metacerkariae from the liver fluke, Fasciola hepatica L.
    Thorsell W; Björkman N; Wittander G
    Experientia; 1965 Oct; 2(10):587-9. PubMed ID: 4288150
    [No Abstract]   [Full Text] [Related]  

  • 35. 3-Mercaptopicolinic acid and energy metabolism in the liver fluke, Fasciola hepatica.
    Kane HJ; Bryant C
    Int J Parasitol; 1984 Aug; 14(4):383-9. PubMed ID: 6469453
    [No Abstract]   [Full Text] [Related]  

  • 36. The diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica.
    Edwards J; Brown M; Peak E; Bartholomew B; Nash RJ; Hoffmann KF
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003604. PubMed ID: 25768432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro maintenance of Fasciola hepatica: a factorial approach based on egg production.
    Ractliffe LH; Guevara-Pozo D; Lopez-Roman R
    Exp Parasitol; 1969 Sep; 26(1):41-51. PubMed ID: 5362314
    [No Abstract]   [Full Text] [Related]  

  • 40. Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance.
    Beesley NJ; Williams DJ; Paterson S; Hodgkinson J
    Int J Parasitol; 2017 Jan; 47(1):11-20. PubMed ID: 27940066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.